Education
About Us
Working with TipRanks
Follow Us
Caplin Point Laboratories Limited (IN:CAPLIPOINT)
:CAPLIPOINT
CAPLIPOINT Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹1,451.60 - ₹2,636.00
Previous CloseN/A
Volume128.91K
Average Volume (3M)4.91K
Market Cap
₹146.55B
Enterprise Value₹143.58B
Total Cash (Recent Filing)₹9.03B
Total Debt (Recent Filing)₹50.20M
Price to Earnings (P/E)25.9
Beta1.17
Next Earnings
Nov 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 30, 2025Dividend Yield0.28%
Share Statistics
EPS (TTM)20.10
Shares Outstanding76,011,696
10 Day Avg. Volume5,234
30 Day Avg. Volume4,910
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Caplin Point Laboratories Limited News
CAPLIPOINT FAQ
What was Caplin Point Laboratories Limited’s price range in the past 12 months?
Caplin Point Laboratories Limited lowest stock price was ₹1451.60 and its highest was ₹2636.00 in the past 12 months.
What is Caplin Point Laboratories Limited’s market cap?
Caplin Point Laboratories Limited’s market cap is ₹146.55B.
When is Caplin Point Laboratories Limited’s upcoming earnings report date?
Caplin Point Laboratories Limited’s upcoming earnings report date is Nov 06, 2025 which is in 90 days.
How were Caplin Point Laboratories Limited’s earnings last quarter?
Caplin Point Laboratories Limited released its earnings results on Aug 07, 2025. The company reported ₹20.102 earnings per share for the quarter, beating the consensus estimate of N/A by ₹20.102.
Is Caplin Point Laboratories Limited overvalued?
According to Wall Street analysts Caplin Point Laboratories Limited’s price is currently Overvalued.
Does Caplin Point Laboratories Limited pay dividends?
Caplin Point Laboratories Limited pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.28%. See more information on Caplin Point Laboratories Limited dividends here
What is Caplin Point Laboratories Limited’s EPS estimate?
Caplin Point Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Caplin Point Laboratories Limited have?
Caplin Point Laboratories Limited has 76,011,696 shares outstanding.
What happened to Caplin Point Laboratories Limited’s price movement after its last earnings report?
Caplin Point Laboratories Limited reported an EPS of ₹20.102 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.714%.
Which hedge fund is a major shareholder of Caplin Point Laboratories Limited?
Currently, no hedge funds are holding shares in IN:CAPLIPOINT
Company Description
Caplin Point Laboratories Limited
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Glenmark Life Sciences Limited
―
Granules India Limited
―
NATCO Pharma Limited
―
Neuland Laboratories Ltd.
―